Related Experiment Video
Updated: Mar 29, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Perinatal thrombosis: implications for mothers and neonates
1Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital/Ohio State University, and Center for Innovation in Pediatric Practice, Research Institute at Nationwide Children's Hospital, Columbus, OH.
Perinatal stroke, including perinatal arterial ischemic stroke (PAIS) and cerebral sinovenous thrombosis (CSVT), presents significant risks for long-term disabilities. Current treatments are limited, with a need for better prevention and therapeutic strategies.
Area of Science:
- Neurology
- Pediatrics
- Neonatology
Background:
- Perinatal stroke is a leading cause of childhood neurological and motor disabilities.
- It encompasses perinatal arterial ischemic stroke (PAIS) and cerebral sinovenous thrombosis (CSVT).
- Etiology is multifactorial, involving maternal, delivery, and neonatal factors.
Purpose of the Study:
- To review the epidemiology, natural history, risk factors, and treatment of PAIS and CSVT.
- To identify current knowledge gaps and areas for future research.
- To evaluate the role of thrombophilia screening and anticoagulation strategies.
Main Methods:
- Literature review of epidemiological data.
- Analysis of risk factors and etiological contributions.
- Evaluation of current and emerging treatment strategies.
Main Results:
- Perinatal stroke etiology is multifactorial; inherited thrombophilia requires further study but routine screening is not recommended.
- Treatment strategies for PAIS are limited; neuroprotection and alternative therapies are needed.
- Anticoagulation in CSVT appears safe and may prevent progression, but clinical trials are necessary to confirm efficacy.
Conclusions:
- Significant morbidity associated with perinatal stroke necessitates improved prevention and treatment.
- Further research into neuroprotection for PAIS and robust clinical trials for CSVT anticoagulation are crucial.
- Understanding the role of thrombophilia in long-term outcomes requires additional investigation.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Pulmonary Embolism III: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

